Skip to main content

Advertisement

Log in

COBRA-BPS programme cost effective for hypertension in Asia

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2020 US dollars

Reference

  • Finkelstein EA, et al. Budget impact and cost-effectiveness analyses of the COBRA-BPS multicomponent hypertension management programme in rural communities in Bangladesh, Pakistan, and Sri Lanka. The Lancet Global Health : 19 Mar 2021. Available from: URL: https://doi.org/10.1016/S2214-109X(21)00033-4

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

COBRA-BPS programme cost effective for hypertension in Asia. PharmacoEcon Outcomes News 875, 3 (2021). https://doi.org/10.1007/s40274-021-7582-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-021-7582-6

Navigation